Mirada Medical develops medical imaging and AI powered automation software applications that provide simple and accessible solutions to complex image analysis problems in the diagnosis and treatment of cancer and other diseases. Through automation, our products improve consistency and productivity while enabling clinicians to deliver more personalized care. By combining deep learning technology with thorough understanding of the challenges faced in oncology today, Mirada is leading the development of next generation imaging software and decision support products.
Location: United States, Ohio, Oxford
Employees: 51-200
Founded date: 2000
Investors 3
Mentions in press and media 3
| Date | Title | Description |
| 03.08.2023 | ConcertAI’s TeraRecon Adds Mirada Medical to its AI Partner Program and Comprehensive Oncology Imaging Solutions | ConcertAI’s TeraRecon, the advanced visualization and clinical AI SaaS company, announced the integration of MiradaXD, the multi-modality nuclear medicine imaging software by Mirada Medical, into its AI partner program. This expands its abi... |
| 08.04.2019 | Pinterest Keeps It Modest, Lyft Sheds Its ‘Nice Guy’ Image, and Grab Is All About the Billions: Term Sheet for Monday, April 8 | MODEST EXPECTATIONS Pinterest remains modest in all aspects of its business. The social media platform set a price range of $15 to $17 for its initial public offering, which puts it below the valuation at which it last raised private money.... |
| 06.04.2014 | Mirada Medical Receives Funding | Mirada Medical, an Oxford, United Kingdom, and Denver, CO-based provider of a software product for doctors to use medical images to diagnose and treat cancer, received an additional funding. UK-based Albion Ventures is investing a further £... |